Risk-stratified management strategies for intrahepatic cholestasis of pregnancy: A tertiary center population review over nearly 5 years

Int J Gynaecol Obstet. 2024 Jan;164(1):219-226. doi: 10.1002/ijgo.14987. Epub 2023 Jul 20.

Abstract

Objective: Intrahepatic cholestasis of pregnancy (ICP) is associated with an increased risk of adverse perinatal outcomes, resulting in a higher risk of perinatal morbidity and mortality.

Methods: The authors conducted a retrospective study of 2385 singletons with ICP who underwent risk-stratified management strategies. To explore the risks of perinatal outcomes of ICP, subgroup analyses were performed using different total bile acid (TBA) levels.

Results: In this study, there was only one stillbirth and one neonatal death. Among the study cohort, 2299 patients had ICP with a TBA level ≥10 μmol/L and 86 had ICP with a TBA level <10 μmol/L. The 2299 patients with ICP (TBA level ≥ 10 μmol/L) were divided into three groups: mild ICP (n = 1803), severe ICP (n = 400), and extremely severe ICP (n = 96). Increased TBA concentration was associated with an increased incidence of preterm birth, newborn asphyxia, neonatal intensive care unit hospitalization, meconium-stained amniotic fluid, and low birth weight in the three groups (P < 0.05). Furthermore, severe and extremely severe ICP with hypotonic absonant uterine contraction had a significant effect on neonatal asphyxia (odds ratio, 5.06 [95% confidence interval, 1.09-23.37]; P < 0.05) and meconium-stained amniotic fluid (odds ratio, 2.37 [95% confidence interval, 1.43-3.93]; P < 0.05).

Conclusions: Hypotonic absonant uterine contractions could be high-risk stressors for severe and extremely severe ICP; hence, proper prenatal care is recommended. Risk-stratified management strategies for ICP are critical to obtaining better maternal-fetal outcomes.

Keywords: intrahepatic cholestasis of pregnancy; perinatal management; perinatal outcomes; retrospective cohort study; risk-stratified management strategies; stillbirth.

MeSH terms

  • Asphyxia / complications
  • Bile Acids and Salts
  • Cholestasis, Intrahepatic* / complications
  • Cholestasis, Intrahepatic* / epidemiology
  • Cholestasis, Intrahepatic* / therapy
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases* / epidemiology
  • Pregnancy
  • Pregnancy Complications* / epidemiology
  • Pregnancy Complications* / therapy
  • Pregnancy Outcome / epidemiology
  • Premature Birth* / epidemiology
  • Retrospective Studies

Substances

  • Bile Acids and Salts

Supplementary concepts

  • Intrahepatic Cholestasis of Pregnancy